Align Technology (NASDAQ:ALGN) and Its Rivals Head-To-Head Contrast

Align Technology (NASDAQ: ALGN) is one of 84 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it compare to its rivals? We will compare Align Technology to similar companies based on the strength of its risk, analyst recommendations, institutional ownership, dividends, earnings, profitability and valuation.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Align Technology and its rivals, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Align Technology 0 0 10 0 3.00
Align Technology Competitors 180 1144 2503 89 2.64

Align Technology currently has a consensus price target of $213.20, suggesting a potential downside of 9.64%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 8.28%. Given Align Technology’s rivals higher probable upside, analysts plainly believe Align Technology has less favorable growth aspects than its rivals.

Insider and Institutional Ownership

81.4% of Align Technology shares are owned by institutional investors. Comparatively, 66.2% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 1.6% of Align Technology shares are owned by company insiders. Comparatively, 11.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Align Technology and its rivals gross revenue, earnings per share and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Align Technology $1.24 billion $306.55 million 71.50
Align Technology Competitors $827.23 million $159.50 million 41.26

Align Technology has higher revenue and earnings than its rivals. Align Technology is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.


This table compares Align Technology and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Align Technology 19.98% 26.48% 18.74%
Align Technology Competitors -126.70% -36.66% -10.08%

Risk and Volatility

Align Technology has a beta of 1.54, suggesting that its share price is 54% more volatile than the S&P 500. Comparatively, Align Technology’s rivals have a beta of 1.06, suggesting that their average share price is 6% more volatile than the S&P 500.


Align Technology beats its rivals on 10 of the 13 factors compared.

Align Technology Company Profile

Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with's FREE daily email newsletter.

Leave a Reply